What is the confirmed 2025 market size and projected 2035 value for the veterinary diagnostic imaging market?
The market was valued at USD 2,145.8 million in 2025 and is forecast to reach USD 4,289.5 million by 2035 at an 8.0% CAGR. Digital radiography (DR) is the dominant segment by installed base revenue. Ultrasound is the highest procedure-volume modality. CT is the fastest-growing high-capital modality by revenue. Companion animals are the dominant species segment. North America holds the largest geographic share; Asia-Pacific is the fastest-growing region from the DR analogue-to-digital transition opportunity across a large developing market installed base.

What drives the direct digital radiography (DR) replacement of computed radiography (CR) as the primary capital equipment cycle?
Direct digital radiography systems — replacing CR phosphor plate processing with immediate flat-panel or linear-array digital sensor acquisition — eliminate the CR processing step delay (15–20 minutes per cassette), provide superior image quality at lower radiation dose, enable immediate DICOM archiving, and integrate directly with PACS and telemedicine radiology consultation platforms. CR-to-DR conversion is the dominant capital equipment upgrade cycle in companion animal practice radiography globally, with the large legacy CR installed base across general companion animal practices creating sustained replacement revenue as CR systems reach end of service life.

How does ultrasound sustain the highest imaging procedure volume across all veterinary modalities?
Veterinary ultrasound — providing real-time soft tissue evaluation without ionising radiation at a cost per study below CT or MRI — is the highest-volume advanced imaging modality across companion animal practice, equine field medicine, and livestock production. Abdominal organ evaluation, cardiac echocardiography, reproductive ultrasound, and FAST emergency examination are the primary volume applications. Portable and handheld POCUS devices enable point-of-care imaging without dedicated suite infrastructure, extending ultrasound access to field equine practice, farm animal production, and companion animal practices without fixed ultrasound suites.

What is driving multimodality companion animal oncology imaging demand above baseline?
Companion animal cancer screening platforms entering routine annual wellness protocols are identifying confirmed cancer patients requiring CT staging (thorax, abdomen, lymph nodes), MRI evaluation (intracranial tumours, spinal cord compression, soft tissue extent), and ultrasound-guided biopsy (abdominal organ masses, lymphadenopathy). Each confirmed cancer diagnosis generates a multimodality imaging cascade worth USD 2,000–8,000 in specialist hospital imaging fees. As cancer screening adoption grows, the number of cancer patients requiring imaging staging grows proportionately — sustaining above-baseline imaging equipment utilisation at specialist referral centres.

How do PACS and cloud-based imaging platforms create recurring software revenue above hardware?
Cloud-based PACS platforms — enabling digital imaging archive, multi-site image access, telemedicine radiologist submission, and AI-assisted image analysis — create recurring annual subscription revenue above the one-time DR hardware capital purchase. Veterinary-specific cloud PACS platforms such as Asteris, Eklin, and IDEXX Web PACS sustain software revenue from the growing installed base of digital imaging practices, with per-study storage, telemedicine submission, and AI analysis creating usage-based revenue above flat subscription models.

Which regional markets are growing fastest and what is driving expansion?
Asia-Pacific is the fastest-growing regional market from the large-scale analogue-to-digital radiography transition opportunity across China, India, Southeast Asia, and South Korea — where a large legacy analogue film and CR installed base is converting to DR as companion animal practice standards rise. The Middle East is a rapidly growing market from specialist veterinary hospital investment in the UAE and Saudi Arabia. Latin America is growing from corporate companion animal hospital chain expansion in Brazil and Mexico.